• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

归因于慢性阻塞性肺疾病分类和肺功能降低的死亡率风险:一项 21 年的纵向队列研究。

Mortality risk attributable to classification of chronic obstructive pulmonary disease and reduced lung function: A 21-year longitudinal cohort study.

机构信息

Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, China.

Department of Public Health, National Cheng Kung University, Tainan, Taiwan.

出版信息

Respir Med. 2021 Aug;184:106471. doi: 10.1016/j.rmed.2021.106471. Epub 2021 May 15.

DOI:10.1016/j.rmed.2021.106471
PMID:34022503
Abstract

AIM

The mortality risk attributable to the classifications of chronic obstructive pulmonary disease (COPD) remains unclear. We investigated the associations of mortality with COPD classifications and reduced lung function in a large longitudinal cohort in Taiwan.

METHODS

A total of 388,401 adults (≥25 years of age) were recruited between 1996 and 2016 underwent 834,491 medical examinations including spirometry. We used the Global Initiative for Chronic Obstructive Lung Disease (GOLD) to establish the COPD classifications. A time-dependent Cox regression model was used to investigate the associations between the morality risk and COPD classifications. We also examined the associations between mortality and lung function.

RESULTS

The mean age of the participants was 42.1 years, and the median follow-up duration was 16.2 years. We identified 28,283 natural-cause deaths, and the mortality rate was 4.7 per 1,000 person-years. The hazard ratios (HRs) [95%confidence interval (95%CI)] of mortality in the participants with restrictive spirometry pattern and COPD GOLD Ⅰ-Ⅳ were 1.31 (1.27-1.35), 1.18 (1.00-1.39), 1.43 (1.35-1.51), 1.78 (1.66-1.90), and 2.13 (1.94-2.34), respectively, with reference to the participants with normal lung function. The natural-cause mortality risk increased by 33% [HR(95%CI): 1.33 (1.28-1.39)] for participants with COPD. Reduced lung function was also associated with a higher mortality risk.

CONCLUSIONS

A more advanced classification of COPD was associated with a greater increase in the mortality risk. Our study suggests that early detection of COPD and slowing the disease progress in patients with COPD are crucial for mortality prevention.

摘要

目的

慢性阻塞性肺疾病(COPD)分类的死亡率风险尚不清楚。我们在台湾的一个大型纵向队列中研究了死亡率与 COPD 分类和肺功能降低的关系。

方法

共有 388401 名成年人(≥25 岁)于 1996 年至 2016 年期间接受了 834491 次包括肺活量测定在内的体检。我们使用全球慢性阻塞性肺疾病倡议(GOLD)来确定 COPD 分类。使用时间依赖性 Cox 回归模型来研究死亡率与 COPD 分类之间的关系。我们还检查了死亡率与肺功能之间的关系。

结果

参与者的平均年龄为 42.1 岁,中位随访时间为 16.2 年。我们确定了 28283 例自然原因死亡,死亡率为每 1000 人年 4.7 例。在有限制性肺通气模式和 COPD GOLD Ⅰ-Ⅳ的参与者中,死亡率的危险比(HR)[95%置信区间(95%CI)]分别为 1.31(1.27-1.35)、1.18(1.00-1.39)、1.43(1.35-1.51)、1.78(1.66-1.90)和 2.13(1.94-2.34),与肺功能正常的参与者相比。患有 COPD 的参与者的自然原因死亡率风险增加了 33%[HR(95%CI):1.33(1.28-1.39)]。肺功能降低也与更高的死亡率风险相关。

结论

更先进的 COPD 分类与死亡率风险的增加有关。我们的研究表明,早期发现 COPD 并减缓 COPD 患者的疾病进展对于预防死亡至关重要。

相似文献

1
Mortality risk attributable to classification of chronic obstructive pulmonary disease and reduced lung function: A 21-year longitudinal cohort study.归因于慢性阻塞性肺疾病分类和肺功能降低的死亡率风险:一项 21 年的纵向队列研究。
Respir Med. 2021 Aug;184:106471. doi: 10.1016/j.rmed.2021.106471. Epub 2021 May 15.
2
The effect of changes to GOLD severity stage on long term morbidity and mortality in COPD.COPD 中 GOLD 严重程度分期变化对长期发病率和死亡率的影响。
Respir Res. 2018 Dec 12;19(1):249. doi: 10.1186/s12931-018-0960-3.
3
GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway.GOLD 分类与慢性阻塞性肺疾病死亡率:挪威亨于普研究。
Thorax. 2013 Oct;68(10):914-21. doi: 10.1136/thoraxjnl-2013-203270. Epub 2013 Apr 23.
4
Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study.应用 2017 年新版全球慢性阻塞性肺疾病倡议分类标准预测慢性阻塞性肺疾病患者的死亡率:一项队列研究。
Lancet Respir Med. 2018 Mar;6(3):204-212. doi: 10.1016/S2213-2600(18)30002-X. Epub 2018 Jan 10.
5
Validation of the GOLD 2017 and new 16 subgroups (1A-4D) classifications in predicting exacerbation and mortality in COPD patients.验证慢性阻塞性肺疾病(COPD)患者中GOLD 2017及新的16个亚组(1A - 4D)分类在预测急性加重和死亡率方面的作用。
Int J Chron Obstruct Pulmon Dis. 2018 Oct 18;13:3425-3433. doi: 10.2147/COPD.S179048. eCollection 2018.
6
Classification of Airflow Limitation Based on z-Score Underestimates Mortality in Patients with Chronic Obstructive Pulmonary Disease.基于 z 评分的气流受限分类低估了慢性阻塞性肺疾病患者的死亡率。
Am J Respir Crit Care Med. 2017 Aug 1;196(3):298-305. doi: 10.1164/rccm.201611-2265OC.
7
Effect of long-term exposure to fine particulate matter on lung function decline and risk of chronic obstructive pulmonary disease in Taiwan: a longitudinal, cohort study.长期暴露于细颗粒物对台湾地区肺功能下降和慢性阻塞性肺疾病风险的影响:一项纵向队列研究。
Lancet Planet Health. 2018 Mar;2(3):e114-e125. doi: 10.1016/S2542-5196(18)30028-7. Epub 2018 Mar 2.
8
Lung function decline and outcomes in an adult population.成年人群的肺功能下降及预后
Am J Respir Crit Care Med. 2006 May 1;173(9):985-90. doi: 10.1164/rccm.200508-1344OC. Epub 2006 Jan 26.
9
The Obstructive Lung Disease in Northern Sweden Chronic Obstructive Pulmonary Disease Study: design, the first year participation and mortality.瑞典北部阻塞性肺病慢性阻塞性肺疾病研究:设计、第一年参与情况及死亡率
Clin Respir J. 2008 Oct;2 Suppl 1:64-71. doi: 10.1111/j.1752-699X.2008.00086.x.
10
Quantitative Vertebral Bone Density Seen on Chest CT in Chronic Obstructive Pulmonary Disease Patients: Association with Mortality in the Korean Obstructive Lung Disease Cohort.慢性阻塞性肺疾病患者胸部 CT 上的定量椎体骨密度:与韩国阻塞性肺疾病队列的死亡率的关系。
Korean J Radiol. 2020 Jul;21(7):880-890. doi: 10.3348/kjr.2019.0551.

引用本文的文献

1
Creation of a Rehabilitation Prediction Rule: a Prioritization Procedure.康复预测规则的创建:一种优先级排序程序。
Can Geriatr J. 2025 Jun 4;28(2):161-168. doi: 10.5770/cgj.28.826. eCollection 2025 Jun.
2
Cost-effectiveness of chronic obstructive pulmonary disease population screening in China: based on individual data from WHO Collaborating Centre-initiated 'Enjoying Breathing Program'.中国慢性阻塞性肺疾病人群筛查的成本效益:基于世界卫生组织合作中心发起的“畅享呼吸计划”的个体数据
BMC Public Health. 2025 Apr 24;25(1):1528. doi: 10.1186/s12889-025-22506-9.
3
Risk of All-Cause Mortality in Mild Chronic Obstructive Pulmonary Disease: Evidence From the NHANES III and 2007-2012.
轻度慢性阻塞性肺疾病全因死亡风险:来自美国国家健康和营养检查调查III及2007 - 2012年的数据
Int J Chron Obstruct Pulmon Dis. 2025 Jan 30;20:217-229. doi: 10.2147/COPD.S497634. eCollection 2025.
4
A CT-Based Lung Radiomics Nomogram for Classifying the Severity of Chronic Obstructive Pulmonary Disease.一种基于CT的用于对慢性阻塞性肺疾病严重程度进行分类的肺影像组学列线图。
Int J Chron Obstruct Pulmon Dis. 2024 Dec 11;19:2705-2717. doi: 10.2147/COPD.S483007. eCollection 2024.
5
Mortality prevention as the centre of COPD management.将预防死亡作为慢性阻塞性肺疾病管理的核心。
ERJ Open Res. 2024 Jun 17;10(3). doi: 10.1183/23120541.00850-2023. eCollection 2024 May.
6
Impact of Smoking and Chronic Obstructive Pulmonary Disease on All-Cause, Respiratory, and Cardio-Cerebrovascular Mortality.吸烟和慢性阻塞性肺疾病对全因、呼吸和心脑血管死亡率的影响。
Int J Chron Obstruct Pulmon Dis. 2024 Jun 7;19:1261-1272. doi: 10.2147/COPD.S458356. eCollection 2024.
7
Low lung function in Bipolar Disorder and Schizophrenia: a hidden risk.双相情感障碍和精神分裂症患者的低肺功能:一个隐藏的风险。
Front Physiol. 2024 Apr 25;15:1335798. doi: 10.3389/fphys.2024.1335798. eCollection 2024.
8
Impaired lung function and lung cancer risk in 461 183 healthy individuals: a cohort study.461183 名健康个体的肺功能受损与肺癌风险:一项队列研究。
BMJ Open Respir Res. 2024 May 7;11(1):e001936. doi: 10.1136/bmjresp-2023-001936.
9
Longitudinal BMI change and outcomes in Chronic Obstructive Pulmonary Disease: a nationwide population-based cohort study.纵向 BMI 变化与慢性阻塞性肺疾病结局的关系:一项全国性基于人群的队列研究。
Respir Res. 2024 Mar 30;25(1):150. doi: 10.1186/s12931-024-02788-0.
10
Treatment patterns in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL).中国稳定期 COPD 患者的治疗模式:一项前瞻性、52 周、全国性、观察性队列研究(REAL)的分析。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231158283. doi: 10.1177/17534666231158283.